Accessibility Statement

We are committed to providing a website that is accessible to the widest possible audience. To do so, we are actively working with consultants to update the website by increasing its accessibility and usability by persons who use assistive technologies such as automated tools, keyboard-only navigation, and screen readers.

We are working to have the website conform to the relevant standards of the Section 508 Web Accessibility Standards developed by the United States Access Board, as well as the World Wide Web Consortium's (W3C) Web Content Accessibility Guidelines 2.1. These standards and guidelines explain how to make web content more accessible for people with disabilities. We believe that conformance with these standards and guidelines will help make the website more user friendly for all people.

Our efforts are ongoing. While we strive to have the website adhere to these guidelines and standards, it is not always possible to do so in all areas of the website. If, at any time, you have specific questions or concerns about the accessibility of any particular webpage, please contact WebsiteAccess@tenethealth.com so that we may be of assistance.

Thank you. We hope you enjoy using our website.

Skip to Main Content

Implant Alternative to Reduce Risk of Stroke in Afib Patients

Oct 22, 2015

Delray Beach, Fla. (October 23, 2015) – With the new WATCHMAN Left Atrial Appendage Closure (LAAC) Implant now offered at Delray Medical Center, patients with non-valvular atrial fibrillation (Afib) have an alternative option to reduce their risk of suffering an Afib-related stroke.

Afib patients have a five times greater risk of stroke and typically have to take long-term warfarin medication, a blood-thinning drug with potentially serious side effects. For those who have reason to seek a non-drug alternative, the WATCHMAN LAAC Implant works by closing off an area of the heart called the left atrial appendage (LAA). By doing so, harmful blood clots that may form due to Afib are kept from entering the blood stream and potentially causing a stroke. Over time, patients may be able to stop taking warfarin.  

“WATCHMAN is just one of several cutting-edge procedures we have started performing in recent years to provide the best possible care for our cardiovascular patients,” said Mark Bryan, hospital CEO. “The combination of our advanced tools and technology and the outstanding judgment and ability of our cardiac team is what helps us achieve positive outcomes.”

Dr. Brijeshwar Maini, an interventional cardiologist and medical director of transcatheter therapies for Tenet Healthcare’s Florida region, recently performed the first WATCHMAN procedure at Delray Medical Center.

“We are proud to be one of the first hospitals in the area to provide Afib patients with a potentially life-changing stroke risk treatment option,” Dr. Maini said. “This device could free patients from the challenges that may come along with long-term warfarin therapy.”

Implanting the WATCHMAN Device is a one-time procedure that usually lasts about an hour. Following the procedure, patients typically need to stay in the hospital for 24 hours.

Sign Up for Health Tips

Get our advice and upcoming events about weight, pain, heart and more.

Find a Doctor

Need a doctor for your care?